References
1. International Classification of Sleep Disorders. Diagnostic and coding manual, revised 1997. Rochester (MN): American Sleep Disorders Association;
2. Ohayon MM, Priest RG, Zulley J, Smirne S, Pavia T. Prevalence of narcolepsy symptomatology and diagnosis in the European general population. Neurology 2002. 581826–1833.
5. Johns MW. A new method of measuring sleepiness: the Epworth sleepiness scale. Sleep 1991. 14540–545.
6. Hoddes E, Zarcone V, Smythe H, Smythe H, Phillips R, Dement WC. Quantification of sleepiness: a new approach. Psychophysiology 1973. 10431–436.
7. Rosenthal L, Roehr TA, Roth T. The sleep-wake activity inventory: a self-report measure of daytime sleepiness. Biol Psychiatry 1993. 34810–820.
8. Richardson G, Carskadon M, Flagg W, Van den Hoed J, Dement WC, Mitler MM. Excessive daytime sleepiness in man: multiple sleep latency measurements in narcoleptic and control subjects. Electroencephalogr Clin Neurophysiol 1978. 45621–627.
9. Johns MW, Hocking B. Daytime sleepiness and sleep habits of Australian workers. Sleep 1997. 20844–849.
10. Rechtschaffen A, Kales A, eds. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects 1968. Washington D.C.: U.S. Public Health Service, U.S. Government Printing Office;
11. Carskadon MA, Dement WC, Mitler MM, Roth T, Westbrook PR, Keenan S. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 1986. 9519–524.
12. Thorpy MJ. The Standards of Practice Committee of the American Sleep Disorders Association. The clinical use of the Multiple Sleep Latency Test. Sleep 1992. 15268–276.
13. American Academy of Sleep Medicine. ICSD-2-International classification of sleep disorders. Diagnostic and coding manual 2005. 2nd edth ed. American Academy of Sleep Medicine;
14. Banks S, Cacheside P, Lack LC, Gunstein RR, McEvoy RD. The maintenance of wakefulness test and driving simulator performance. Sleep 2005. 281360–1361.
15. Park YJ, Lee WC, Lim HW, Park YM. The association between sleep duration and obesity in Korean adults. J Prev Med Public Health 2007. 40454–460.
16. Roehrs TA, Shore E, Papineau K, Rosenthal L, Roth T. A two-week sleep extension in sleepy normals. Sleep 1996. 19576–582.
17. Melendres CS, Lutz JM, Rubin ED, Marcus CL. Daytime sleepiness and hyperactivity in children with suspected sleep-disordered breathing. Pediatrics 2004. 114768–775.
18. Golan N, Shahar E, Ravid S, Pillar G. Sleep disorders and daytime sleepiness in children with attention-deficit/hyperactive disorder. Sleep 2004. 27261–266.
19. Rosen CL, Storfer-Isser A, Taylor HG, Kirchner HL, Emancipator JL, Redline S. Increased behavioral morbidity in school-aged children with sleep-disordered breathing. Pediatrics 2004. 1141640–1648.
20. Chervin RD, Archbold KH, Dillon JE, Panahi P, Pituch KJ, Dahl RE, Guilleminault C. Inattention, hyperactivity, and symptoms of sleep-disordered breathing. Pediatrics 2002. 109449–456.
21. Picchietti DL, England SJ, Walters AS, Willis K, Verrico T. Periodic limb movements disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. J Child Neurol 1998. 13588–594.
22. Picchietti DL, Walters AS. Moderate to severe periodic limb movements disorder in childhood and adolescence. Sleep 1999. 22297–300.
23. Hong SC, Lin Ling, Jeong JH, Han JH, Lee JH, Lee SP, Zhang Jing, Einen Mali, Mignot Emmanuel. A study of the diagnostic utility of HLA-typing, CSF hypocretin-1 measurements and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness. Sleep 2006. 291429–1438.
24. Hong SC, Lin L, Lo B, Jeong JH, Shin YK, Kim SY, Kweon YS, Zhang Jing, Einen Mali, Smith Anajane, Hansen John, Grumet F.Carl, Mignot Emmanuel. DQB1*0301 and DQB10601 modulate narcolepsy susceptibility in Koreans. Human Immunology 2007. 6859–68.
25. Diagnostic and Statistical Mannual of Mental Disorders: DSM-IV-TR 2000. 4th edth ed. Washington (DC): American Psychiatric Association;
26. Tylee A, Gastpar M, Lepine JP, Mendlewicz J. DEPRES Steering Committee. DEPRES II (Depression Research in European Society II): a patient survey of the symptoms, disability and current management of depression in the community. Int Clin Psychopharmacol 1999. 14139–151.
27. Reynolds CF 3rd, Coble PA, Kupfer DJ, Holzer BC. Application of the multiple sleep latency test in disorders of excessive sleepiness. Electroencephalogr Clin Neurophysiol 1982. 53443–452.
28. Chesson AL Jr, Littner M, Davila D, Anderson WM, Griqq-Damberger M, Hartse K, Johnson S, Wise M. Practice parameters for the use of light therapy in the treatment of sleep disorders. Standards of Practice Committee, American Academy of Sleep Medicine. Sleep 1999. 22641–660.
29. Czeisler CA. Commentary: evidence for melatonin as a circadian phase-shifting agent. J Biol Rhythms 1997. 12618–623.
30. Patel SR, White DP, Malhotra A, Stanchina ML, Ayas NT. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. Arch Intern Med 2003. 163565–571.
31. Morisson F, Decary A, Petit D, Lavigne G, Malo J, Montplaisir J. Daytime sleepiness and EEG spectral analysis in apneic patients before and after treatment with continuous positive airway pressure. Chest 2001. 11945–52.
32. Allen RP, Early CJ. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol 2001. 18128–147.
33. Allen R, Becker PM, Bogan R, Schmidt M, Kushida CA, Fry JM, Poceta JS, Winslow D. Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome. Sleep 2004. 27907–914.
34. Trenwalder C, Garcia-Borreguero D, Montagna P, Lainey E, de Weerd AW, Tidswell P, Saletu-Zyhlarz G, Telstad W, Ferini-Starambi L. Ropinirole in the treatment of restless legs syndrome: results form the TREAT RLS1 study, a 12 week, randomized, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry 2004. 7592–97.
35. US Xyrem in Narcolepsy Multi-center Study Group. A randomized, double blind, placebocontrolled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep 2002. 2542–49.
36. Mamelak M, Black J, Monplaisir J, Ristanovic R. A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy. Sleep 2004. 271327–1334.
37. Black J, Houghton WC. Sodium oxybate improves excessive daytime sleepiness in narcolepsy. Sleep 2006. 29939–946.